Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 562

1.

BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.

Xu Y, Jiang WG, Wang HC, Martin T, Zeng YX, Zhang J, Qi YS.

Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5093-5100. doi: 10.26355/eurrev_201906_18173.

PMID:
31298409
2.

Development and validation of a gene expression test to identify hard-to-heal chronic venous leg ulcers.

Bosanquet DC, Sanders AJ, Ruge F, Lane J, Morris CA, Jiang WG, Harding KG.

Br J Surg. 2019 Jul;106(8):1035-1042. doi: 10.1002/bjs.11161. Epub 2019 May 16.

PMID:
31095725
3.

Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer.

Zhao C, Tao T, Yang L, Qin Q, Wang Y, Liu H, Song R, Yang X, Wang Q, Gu S, Xiong Y, Zhao D, Wang S, Feng D, Jiang WG, Zhang J, He J.

Cancer Lett. 2019 Jul 1;453:107-121. doi: 10.1016/j.canlet.2019.03.043. Epub 2019 Mar 29.

PMID:
30930234
4.

Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis.

Zhong W, Tan L, Jiang WG, Chen K, You N, Sanders AJ, Liang G, Liu Z, Ling Y, Gong C.

J Surg Oncol. 2019 Jun;119(8):1039-1046. doi: 10.1002/jso.25457. Epub 2019 Mar 20.

PMID:
30892719
5.

Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer.

Wazir U, Orakzai MMAW, Martin TA, Jiang WG, Mokbel K.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):121-127. doi: 10.21873/cgp.20117.

6.

Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.

Li S, Ma J, Si Y, Cheng S, Hu M, Zhi X, Li B, Yu H, Jiang WG.

Int J Oncol. 2019 May;54(5):1747-1758. doi: 10.3892/ijo.2019.4732. Epub 2019 Feb 27.

PMID:
30816447
7.

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells.

Flamini V, Dudley E, Jiang WG, Cui Y.

Oncotarget. 2018 Nov 23;9(92):36474-36491. doi: 10.18632/oncotarget.26356. eCollection 2018 Nov 23.

8.

DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways.

Zhao H, Chen G, Ye L, Yu H, Li S, Jiang WG.

Int J Oncol. 2019 Jan;54(1):381-389. doi: 10.3892/ijo.2018.4624. Epub 2018 Nov 5.

PMID:
30431081
9.

mRNA Expression of CDK2AP1 in Human Breast Cancer: Correlation with Clinical and Pathological Parameters.

Gera R, Mokbel L, Jiang WG, Mokbel K.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):447-452. doi: 10.21873/cgp.20103.

10.

Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.

Collins RJ, Morgan LD, Owen S, Ruge F, Jiang WG, Sanders AJ.

Int J Cancer. 2018 Nov 15;143(10):2537-2550. doi: 10.1002/ijc.31786. Epub 2018 Sep 19.

PMID:
30098000
11.

Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.

Li L, Cui Y, Ye L, Zhao Z, Jiang WG, Ji J.

Int J Oncol. 2018 Sep;53(3):1171-1182. doi: 10.3892/ijo.2018.4455. Epub 2018 Jun 26.

PMID:
29956751
12.

Impact of pigment epithelium-derived factor on colorectal cancer in vitro and in vivo.

Harries RL, Owen S, Ruge F, Morgan M, Li J, Zhang Z, Harding KG, Torkington J, Jiang WG, Cai J.

Oncotarget. 2018 Apr 10;9(27):19192-19202. doi: 10.18632/oncotarget.24953. eCollection 2018 Apr 10.

13.

[Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.

Gao XY, Li L, Wang XH, Wen XZ, Ji K, Ye L, Cai J, Jiang WG, Ji JF.

Oncol Rep. 2018 Apr;39(4):2051. doi: 10.3892/or.2018.6269. Epub 2018 Feb 14.

14.

[Corrigendum] Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.

Du P, Ye L, Yang Y, Jiang WG.

Int J Oncol. 2018 Apr;52(4):1364. doi: 10.3892/ijo.2018.4277. Epub 2018 Feb 16.

15.

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.

Laprevotte E, Cochaud S, du Manoir S, Lapierre M, Dejou C, Philippe M, Giustiniani J, Frewer KA, Sanders AJ, Jiang WG, Michaud HA, Colombo PE, Bensussan A, Alberici G, Bastid J, Eliaou JF, Bonnefoy N.

Oncotarget. 2017 Dec 6;8(69):113360-113372. doi: 10.18632/oncotarget.23008. eCollection 2017 Dec 26.

16.

Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer.

Riaz SK, Khan JS, Shah STA, Wang F, Ye L, Jiang WG, Malik MFA.

Cell Commun Signal. 2018 Jan 8;16(1):3. doi: 10.1186/s12964-017-0213-y.

17.

CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.

Ma SC, Li Q, Peng JY, Zhouwen JL, Zhang DN, Zhang CB, Jiang WG, Jia W.

Oncol Rep. 2018 Mar;39(3):1441-1453. doi: 10.3892/or.2018.6208. Epub 2018 Jan 10.

PMID:
29328410
18.

Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development.

Dart DA, Uysal-Onganer P, Jiang WG.

Oncogenesis. 2017 Dec 14;6(12):400. doi: 10.1038/s41389-017-0007-5.

19.

Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.

Owen S, Zabkiewicz C, Ye L, Sanders AJ, Gong C, Jiang WG.

Adv Exp Med Biol. 2017;1026:197-216. doi: 10.1007/978-981-10-6020-5_9. Review.

PMID:
29282685
20.

Corrigendum to "Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer" [Eur J Cancer 40 (18) (2004) 2717-2725].

Martin TA, Watkins G, Mansel RE, Jiang WG.

Eur J Cancer. 2018 Jan;88:115-116. doi: 10.1016/j.ejca.2017.11.001. Epub 2017 Nov 23. No abstract available.

PMID:
29174182
21.

Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.

Lopes-Bastos B, Jin L, Ruge F, Owen S, Sanders A, Cogle C, Chester J, Jiang WG, Cai J.

Oncotarget. 2017 Jun 28;8(49):85024-85039. doi: 10.18632/oncotarget.18781. eCollection 2017 Oct 17.

22.

The Effect of Aurora Kinase Inhibitor on Adhesion and Migration in Human Breast Cancer Cells and Clinical Implications.

Zhao H, Owen S, Davies EL, Jiang WG, Martin TA.

World J Oncol. 2017 Oct;8(5):151-161. doi: 10.14740/wjon1062w. Epub 2017 Nov 5.

23.

Lessons From Managing the Breast Malignant Adenomyoepithelioma and the Discussion on Treatment Strategy.

Yuan Z, Qu X, Zhang ZT, Jiang WG.

World J Oncol. 2017 Aug;8(4):126-131. doi: 10.14740/wjon1055e. Epub 2017 Aug 27.

24.

The Effects of Anesthetics on Recurrence and Metastasis of Cancer, and Clinical Implications.

Yang W, Cai J, Zabkiewicz C, Zhang H, Ruge F, Jiang WG.

World J Oncol. 2017 Jun;8(3):63-70. doi: 10.14740/wjon1031e. Epub 2017 Jun 9. Review.

25.

The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint.

Xin L, Liu YH, Martin TA, Jiang WG.

World J Oncol. 2017 Apr;8(2):34-40. doi: 10.14740/wjon1019w. Epub 2017 May 4. Review.

26.

Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways.

Jia J, Martin TA, Ye L, Meng L, Xia N, Jiang WG, Zhang X.

Int J Mol Med. 2018 Jan;41(1):275-283. doi: 10.3892/ijmm.2017.3224. Epub 2017 Oct 27.

27.

Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis.

Ma SC, Li Q, Peng JY, Zhouwen JL, Diao JF, Niu JX, Wang X, Guan XD, Jia W, Jiang WG.

CNS Neurosci Ther. 2017 Dec;23(12):947-960. doi: 10.1111/cns.12764. Epub 2017 Sep 29.

28.

ShenLingLan Influences the Attachment and Migration of Ovarian Cancer Cells Potentially through the GSK3 Pathway.

Owen S, Ruge F, Gao Y, Yang Y, Hou J, Chen J, Feng Y, Zhang H, Gao Y, Wang H, Wei C, Wu Y, Jiang WG.

Medicines (Basel). 2017 Feb 21;4(1). pii: E10. doi: 10.3390/medicines4010010.

29.

Kidins220 and tumour development: Insights into a complexity of cross-talk among signalling pathways (Review).

Cai S, Cai J, Jiang WG, Ye L.

Int J Mol Med. 2017 Oct;40(4):965-971. doi: 10.3892/ijmm.2017.3093. Epub 2017 Aug 9. Review.

30.

In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing.

Feng Y, Sanders AJ, Morgan LD, Owen S, Ruge F, Harding KG, Jiang WG.

Sci Rep. 2017 Jul 27;7(1):6715. doi: 10.1038/s41598-017-06886-6.

32.

Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.

Du P, Wang S, Tang X, An C, Yang Y, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4499-4505.

PMID:
28739745
33.

Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.

Yin J, Cui Y, Li L, Ji J, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4489-4497.

PMID:
28739744
34.

Role of Plexin B1 in a Breast Cancer Cohort of Pakistani Patients and its Contribution Towards Cancer Metastasis as Indicated by an In Vitro Model.

Malik MFA, Riaz SK, Waqar SH, Haq F, Ye L, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4483-4488.

PMID:
28739743
35.

Clinical Correlation Between WISP2 and β-Catenin in Gastric Cancer.

Li L, Cui Y, Ji JF, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4469-4473.

PMID:
28739741
36.

Transcriptional Profiling of Sonic Hedgehog in a Prospective Cohort of Breast Cancer in a Pakistani Population.

Riaz SK, Ye L, Sahar NE, Aman D, Qadir J, Khan JS, Saeed M, Jiang WG, Malik MFA.

Anticancer Res. 2017 Aug;37(8):4449-4454.

PMID:
28739739
37.

Knockdown of EPHA1 Using CRISPR/CAS9 Suppresses Aggressive Properties of Ovarian Cancer Cells.

Cui Y, Wu BO, Flamini V, Evans BAJ, Zhou D, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4415-4424.

PMID:
28739735
38.

NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial-Mesenchymal Transition.

Yang F, Gu Y, Zhao Z, Huang J, Jiang WG, Cheng S.

Anticancer Res. 2017 Aug;37(8):4405-4414.

PMID:
28739734
39.

Reduced Expression of RanBPM Is Associated with Poorer Survival from Lung Cancer and Increased Proliferation and Invasion of Lung Cancer Cells In Vitro.

Zhao Z, Cheng S, Zabkiewicz C, Chen J, Zhang L, Ye L, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4389-4397.

PMID:
28739732
40.

Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma.

Zhao Q, Kun D, Hong B, Deng X, Guo S, Tang X, Yang Y, Gong K, Li Q, Ye L, Jiang WG, Zhang N.

Anticancer Res. 2017 Aug;37(8):4379-4388.

PMID:
28739731
41.

Comparison of Different Muscle-Relaxant Anesthetics on Growth, Migration and Invasion of Gastric Cancer Cells.

Jiang A, Zhao H, Liu X, Yu M, Chen J, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4371-4378.

PMID:
28739730
42.

The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways.

Zheng F, Zhang Z, Flamini V, Jiang WG, Cui Y.

Anticancer Res. 2017 Aug;37(8):4361-4369.

PMID:
28739729
43.

HIF1α-associated circDENND4C Promotes Proliferation of Breast Cancer Cells in Hypoxic Environment.

Liang G, Liu Z, Tan L, Su AN, Jiang WG, Gong C.

Anticancer Res. 2017 Aug;37(8):4337-4343.

PMID:
28739726
44.

Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.

Flamini V, Jiang WG, Cui Y.

Anticancer Res. 2017 Aug;37(8):4319-4327.

PMID:
28739724
45.

Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells.

Yu Z, Sanders AJ, Owen S, Cheng S, Yang X, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4277-4283.

PMID:
28739719
46.

Protein of Vascular Endothelial Growth Inhibitor 174 Inhibits Epithelial-Mesenchymal Transition in Renal Cell Carcinoma In Vivo.

Zhao Q, Deng X, Hong B, Wang F, Tang X, Yang Y, Gong K, Ye L, Jiang WG, Zhang N.

Anticancer Res. 2017 Aug;37(8):4269-4275.

PMID:
28739718
47.

Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.

Sobkowicz AD, Sanders AJ, Mason MD, Jiang WG.

Anticancer Res. 2017 Aug;37(8):4255-4268.

PMID:
28739717
48.

Clinical Significance of PD1 and PDL1 in Human Breast Cancer.

Uhercik M, Sanders AJ, Owen S, Davies EL, Sharma AK, Jiang WG, Mokbel K.

Anticancer Res. 2017 Aug;37(8):4249-4254.

PMID:
28739716
49.

Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance.

Zabkiewicz C, Resaul J, Hargest R, Jiang WG, Ye L.

Endocr Relat Cancer. 2017 Oct;24(10):R349-R366. doi: 10.1530/ERC-17-0139. Epub 2017 Jul 21. Review.

50.

PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation.

Tao T, Yang X, Zheng J, Feng D, Qin Q, Shi X, Wang Q, Zhao C, Peng Z, Liu H, Jiang WG, He J.

Oncogene. 2017 Nov 2;36(44):6119-6131. doi: 10.1038/onc.2017.199. Epub 2017 Jul 10.

PMID:
28692056

Supplemental Content

Loading ...
Support Center